GL1X · GenesisL1 explorer

MolNFT v1 · #94494 · protein

Structural basis and sar for od 270, a lead stage 1,2,4-triazole based specific TANKYRASE1/2 inhibitor

4HYF · Tankyrase-2: “Structural basis and sar for od 270, a lead stage 1,2,4-triazole based specific TANKYRASE1/2 inhibitor”. X-ray diffraction, 3 ligands (NCA, 1AK, ZN), 10 pockets (best druggability 0.72). MolNFT v1 #94494 on GenesisL1…

PDB
4HYF
Type
protein
Length
681 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tankyrase-2
EC
2.4.2.30
UniProt
Q9H2K2
Ligands
NCA, 1AK, ZN
Pockets
10 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 22% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CTankyrase-2 (EC 2.4.2.30)protein22722% helix, 25% strandQ9H2K2

Ligands and binding sites

  • NCA · Nicotinamide · ligand · 3 copies · chains A, B, C
  • 1AK · 4-{5-[(E)-2-{4-(2-chlorophenyl)-5-[5-(methylsulfonyl)pyridin-2-yl]-4H-1,2,4-triazol-3-yl}ethenyl]-1,3,4-oxadiazol-2-yl}benzonitrile · ligand · 3 copies · chains A, B, C
  • ZN · Zinc ion · metal · 3 copies · chains A, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14970.720.8265NCA, 1AK
24870.720.8171NCA, 1AK
32610.680.8331NCA, 1AK
43260.600.7842empty
5690.520.8618empty

Interfaces

2 interfaces between chains.

  • A–C · 1068 Ų buried · 8 hydrogen bonds · protein-protein
  • A–B · 945 Ų buried · 21 hydrogen bonds · protein-protein

Compared structures

  • 4HYF · Structural basis and SAR for OD 270, a lead stage 1,2,4-triazole based specific… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.